SCOPE: This study explores the relationship between aflatoxin and the insulin-like growth factor (IGF) axis and its potential effect on child growth. METHODS AND RESULTS: One hundred and ninety-nine Kenyan schoolchildren were studied for aflatoxin-albumin adduct (AF-alb), IGF1 and IGF-binding protein-3 (IGFBP3) levels using ELISA. AF-alb was inversely associated with IGF1 and IGFBP3 (p < 0.05). Both IGF1 and IGFBP3 were significantly associated with child height and weight (p < 0.01). Children in the highest tertile of AF-alb exposure (>198.5 pg/mg) were shorter than children in the lowest tertile (<74.5 pg/mg), after adjusting for confounders (p = 0.043). Path analysis suggested that IGF1 levels explained ∼16% of the impact of aflatoxin exposure on child height (p = 0.052). To further investigate this putative mechanistic pathway, HHL-16 liver cells (where HHL-16 is human hepatocyte line 16 cells) were treated with aflatoxin B1 (0.5, 5 and 20 μg/mL for 24-48 h). IGF1 and IGFBP3 gene expression measured by quantitative PCR and protein in culture media showed a significant down-regulation of IGF genes and reduced IGF protein levels. CONCLUSION: Aflatoxin treatment resulted in a significant decrease in IGF gene and protein expression in vitro. IGF protein levels were also lower in children with the highest levels of AFB-alb adducts. The data suggest that aflatoxin-induced changes in IGF protein levels could contribute to growth impairment where aflatoxin exposure is high.
SCOPE: This study explores the relationship between aflatoxin and the insulin-like growth factor (IGF) axis and its potential effect on child growth. METHODS AND RESULTS: One hundred and ninety-nine Kenyan schoolchildren were studied for aflatoxin-albumin adduct (AF-alb), IGF1 and IGF-binding protein-3 (IGFBP3) levels using ELISA. AF-alb was inversely associated with IGF1 and IGFBP3 (p < 0.05). Both IGF1 and IGFBP3 were significantly associated with child height and weight (p < 0.01). Children in the highest tertile of AF-alb exposure (>198.5 pg/mg) were shorter than children in the lowest tertile (<74.5 pg/mg), after adjusting for confounders (p = 0.043). Path analysis suggested that IGF1 levels explained ∼16% of the impact of aflatoxin exposure on child height (p = 0.052). To further investigate this putative mechanistic pathway, HHL-16 liver cells (where HHL-16 is human hepatocyte line 16 cells) were treated with aflatoxin B1 (0.5, 5 and 20 μg/mL for 24-48 h). IGF1 and IGFBP3 gene expression measured by quantitative PCR and protein in culture media showed a significant down-regulation of IGF genes and reduced IGF protein levels. CONCLUSION:Aflatoxin treatment resulted in a significant decrease in IGF gene and protein expression in vitro. IGF protein levels were also lower in children with the highest levels of AFB-alb adducts. The data suggest that aflatoxin-induced changes in IGF protein levels could contribute to growth impairment where aflatoxin exposure is high.
Authors: Reginald F Clayton; Angela Rinaldi; Eve E Kandyba; Mike Edward; Christian Willberg; Paul Klenerman; Arvind H Patel Journal: Liver Int Date: 2005-04 Impact factor: 5.828
Authors: Nicolette Arends; Linda Johnston; Anita Hokken-Koelega; Cornelia van Duijn; Maria de Ridder; Martin Savage; Adrian Clark Journal: J Clin Endocrinol Metab Date: 2002-06 Impact factor: 5.958
Authors: Shona Wilson; Birgitte J Vennervald; Hilda Kadzo; Edmund Ireri; Clifford Amaganga; Mark Booth; H Curtis Kariuki; Joseph K Mwatha; Gachuhi Kimani; John H Ouma; Eric Muchiri; David W Dunne Journal: Trans R Soc Trop Med Hyg Date: 2009-10-08 Impact factor: 2.184
Authors: Hector Hernandez-Vargas; Jovita Castelino; Matt J Silver; Paula Dominguez-Salas; Marie-Pierre Cros; Geoffroy Durand; Florence Le Calvez-Kelm; Andrew M Prentice; Christopher P Wild; Sophie E Moore; Branwen J Hennig; Zdenko Herceg; Yun Yun Gong; Michael N Routledge Journal: Int J Epidemiol Date: 2015-04-07 Impact factor: 7.196
Authors: Brittany Knipstein; Jiansheng Huang; Emily Barr; Philip Sossenheimer; Dennis Dietzen; Patricia A Egner; John D Groopman; David A Rudnick Journal: Pediatr Res Date: 2015-05-04 Impact factor: 3.756
Authors: Judith Kuchenbecker; Anika Reinbott; Beatrice Mtimuni; Michael B Krawinkel; Irmgard Jordan Journal: PLoS One Date: 2017-04-20 Impact factor: 3.240
Authors: Laura E Smith; Andrew J Prendergast; Paul C Turner; Jean H Humphrey; Rebecca J Stoltzfus Journal: Am J Trop Med Hyg Date: 2017-04 Impact factor: 2.345
Authors: Titilayo D O Falade; Panagiotis K Chrysanthopoulos; Mark P Hodson; Yasmina Sultanbawa; Mary Fletcher; Ross Darnell; Sam Korie; Glen Fox Journal: Toxins (Basel) Date: 2018-05-07 Impact factor: 4.546
Authors: Sinead Watson; Sophie E Moore; Momodou K Darboe; Gaoyun Chen; Yu-Kang Tu; Yi-Ting Huang; Kamilla G Eriksen; Robin M Bernstein; Andrew M Prentice; Christopher P Wild; Ya Xu; Michael N Routledge; Yun Yun Gong Journal: BMC Public Health Date: 2018-11-09 Impact factor: 3.295